Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Generic Rx Reforms Contribute To Medicare Budget Squeeze

Executive Summary

CBO is predicting only minor savings to the Medicare prescription drug program through Waxman/Hatch reforms contained in the Senate and House versions of the Medicare bill in light of previous reforms announced by FDA
Advertisement

Related Content

Generic Rx Reforms: No Automatic “Controversy” For Declaratory Judgments
CMS Expected To Delay AWP Regulation; Medicare Conferees Want Credit
Generic Drug 180-Day Exclusivity Reform Proposal Is Cost-Neutral, CBO Says
AWP Reform: Competitive Bidding Option Could Save The Most, CMS Says
Medicare Rx Discount Card Rebate Pass-Through Opposed By White House
Generic Drug 180-Day Exclusivity Provisions: Hatch Seeks CBO Score
Rx Reimportation Passes House; CBO Score May Keep It Out Of Medicare Rx
Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says
Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says
AWP Reform: House Bill Offers Choice Of “Average Sales Price” Or Bids
Advertisement
UsernamePublicRestriction

Register

PS042192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel